A B S T R A C T We have found complement-dependent cytotoxic antibodies in the serum of 8 of 24 patients with inisulin-dependent diabetes mellitus using a 5'Cr cytotoxicity assay with monolayers of cloned rat islet cells (clones RINm 5F and RINm 14B). In contrast, complement-dependent cytotoxicity with 5'Cr release >24% was not found with sera from 34 controls or from 5 patients with polyglandular failure without diabetes, and was present in only 1 serum out of 12 from patients with insulin-independent diabetes mellitus. The prevalence of antibodies appears to decrease with duration of insulin-dependent diabetes, and in one patient studied, cytotoxic antibodies were present at the time ofdiagnosis ofdiabetes. Cytotoxicity is independent of insulin synthesis, as evidenced by the linear correlation of cytotoxicity of sera for the insulin-producing clone RINm 5F and the somatostatin-producing clone RINm 14B. The present study identifies nonspecies-specific cytotoxic antibodies in the serum of patients with diabetes mellitus, and the assay used should facilitate studies of humoral immunity in the pathogenesis of diabetes mellitus.
INTRODUCTION
Using indirect immunofluorescent techniques on frozen (1) or Bouin's fixed sections of human pancreas (2) , autoantibodies to pancreatic islet cells have been found in the sera of patients with insulin-dependent diabetes. Recently, a subset of such antibodies has been shown to fix complement (3) . These antibodies decrease in prevalence as a function of the duration of diabetes, and in a number of instances have been detected before the development of disease. It appears that such antibodies react with a cytoplasmic component of islet cells (3) . How such antibodies reacting with the cytoplasm may be pathogenic is not clear, though it is possible that such antibodies reacting with damaged islet cells may enhance inflammatory processes within islets. Serum from insulin-dependent diabetic patients also contains antibodies to the surface of islet cells. Using indirect immunofluorescence, MacLaren and co-workers (4) found antibodies to the surface of a cultured human insulinoma in 34 out of 39 diabetic patients. Lernmark et al. (5) , using a similar technique, have reported the occurrence of antibodies directed against the cell surface of rat islet cells. Rittenhouse and co-workers (6) have described nonspecies-specific factors in the sera of patients with diabetes that are cytotoxic to guinea pig islets. These and other studies have contributed to the development of the hypothesis that autoimmune phenomena are of importance in the pathogenesis of insulin-dependent diabetes mellitus.
Studies of the immunochemistry of anti-islet antibodies and isolation of islet cell antibodies have been hindered by the difficulty in obtaining large quantities of islet cells. Permanent cell lines expressing relevant cell-surface antigens would facilitate such studies. Using monoclonal antibodies directed against cellsurface antigens expressed by the RINm rat islet cell line, we have found that these cultured cells express many antigens (including differentiation antigens) that are present on normal rat pancreatic islet cells (7) . Furthermore, these cells, when grown in monolayer culture, can be used in a sensitive 51Cr cytotoxicity assay. In the present study we Cytotoxicity assay. Serum was prepared for assay by diluting in Dulbecco's phosphate-buffered saline (PBS)l (1:1, vol/vol) heating at 56°C for 30 min and absorbing overnight with 1 mg of rat liver powder (N. L. Cappel Laboratories, Inc., Cochranville, Pa.) per 400 ,ul of diluted serum. Cells for assay were obtained by incubation (5 min at room temperature) with 5 ml of 0.025% trypsin (Worthington Biochemical Co., Freehold, N. J.) in Dulbecco's PBS. The resulting cell suspension was centrifuged at 500 g, the supernate discarded, and the cells resuspended in 10 ml of RPMI 1640 medium supplemented with 10% heat-inactivated (56°C for 30 min) fetal calf serum (2-5 x 106 cells/50 ml). 0.1 ml of the cell suspension was added to each well of a 96-well microculture plate and cultured for 48-96 h before assay. 4-24 h before the assay, medium was removed from each well, and 0.1 ml RPMI medium containing 10% heatinactivated fetal calf serum and 75,000 cpm of 51Cr (counting efficiency 70%) was added. Immediately before assay, the plate was inverted onto a utility wipe and the wells were washed three times with 150 ,ul of RPMI medium. For the cytotoxicity assay, 10 ,ul of RPMI medium was added to each well followed by 50 ,l of a 1:1 (vol/vol) dilution (in PBS) of test serum. After incubation with serum at 37°C for 30 min 60 ,ul of a 1:2 (vol/vol) dilution of rabbit complement in PBS with Ca and Mg was added, and after 30 min at 37C, an aliquot of the medium was harvested with a micropipette or Titertek harvestinig filter (Flow Laboratories, Rockville, Md.) and counted in a gamma counter. Total 5"Cr incorporation was determined by adding 50 ,ul of 0.3% Triton X-100. Release in the absence of antibody (PBS rather than serum) was < 10% of total 5'Cr release. Specific cytotoxicity was calculated as follows: Specific cytotoxicity 51Cr release with test serum -51Cr release with PBS 51Cr release with Triton -51Cr release with PBS Patient population. Serum was obtained from nonhospitalized healthy individuals (control), patients with a history compatible with insulin-dependent diabetes mellitus (ketoacidosis, onset of diabetes mellitus less than age 40, usually less than age 20, receiving insulin), patients with a history compatible with insulin-independent diabetes mellitus (abnormal glucose tolerance test with fasting glucose > 140 mg%, no history of ketoacidosis, treatment with diet, or oral hypoglycemic agents for > 1 yr), and patients with polyglandular failure without diabetes (primarily Addison's disease and autoimmune thyroid disease [9] ). NH4SO4 precipitation. A 1:1 (vol/vol) dilution of serum was incubated in a 45% saturated NH4SO4 solution (pH 7.2) at room temperature for 30 min; the precipitate was washed with 45% saturated NH4SO4 and then redissolved in PBS.
I Abbreviation used in this paper: PBS, phosphate-buffered saline.
Insoluble material was removed by centrifugation at 1,000 g for 15 min (4°C) and the supemate was incubated with 40% saturated NH4SO4 for 30 min (room temperature). The precipitate was then washed once with 40% saturated NH4SO4, redissolved in PBS, and then dialyzed against PBS (50:1) three times.
Incubation of serum with anti-human iinmunobeads. Serum diluted in PBS (1:2, vol/vol) or the redissolved NH4SO4 precipitate was incubated with 2.2 mg/ml of rabbit anti-human IgG immunobeads (specific for y-chains), rabbit anti-human IgM immunobeads (specific for,u-chains), or 1.1 mg/ml of both anti-IgG anti-IgM immunobeads (Bio-Rad Laboratories, Richmond, Calif.) for 60 min at 4°C, after which the immunobeads were removed by centrifugation and the supernates tested for cytotoxicity.
RESULTS
Prevalence ofcytotoxic antibodies. As illustrated in (Fig. 2) . Cytotoxicity depended on incubation with both antibody and rabbit complement (Fig. 3) . In the absence of complement there was essentially no cytotoxicity. Fig. 4 plots the cytotoxicity of serum from patients with insulin-dependent diabetes mellitus vs. the duration of diabetes. All strongly cytotoxic sera were obtained from individuals within 6 Table I , this partially purified antibody preparation was cytotoxic. Furthermore, a 90-min incubation with a combination of anti-human IgG and anti-human IgM immunobeads reduced specific cytotoxicity of this antibody preparation from 45 to 11% (Table I ). The ability of incubation with immunobeads to reduce serum cytotoxicity was also tested with two cytotoxic serums and one noncytotoxic serum without prior ammonium sulfate precipitation (Table   B  A antibody 6B2, which does not react with anti-human immunobeads, was unaffected by the immunobeads. Inhibition of cytotoxicity in some patients by both anti-IgG and anti-IgM immunobeads suggests that the cytotoxic antibodies are polyclonal.
Because both a somatostatin-and insulin-producing subelone of RINm cells were available, we were able to test whether the cytotoxic effect of serum was dependent on insulin synthesis by the cultured cells. Fig. 5 plots specific cytotoxicity against RINm clone 5F cells (x-axis, insulin-producing) vs. cytotoxicity against RINm clone 14B cells (somatostatin-producing). The cytotoxicities against the two cell lines were significantly correlated (r = 0.65, P < 0.01). Sera that resulted in > 24% release of 5tCr from the SF cell line released > 20% of clone 14B-incorporated 5tCr. To determine whether serum from diabetic patients is cytotoxic to nonislet tumors, we tested the effect of three positive sera and two negative sera on the rat GH3 pituitary cell line and the neuroblastoma-glioma It is not known whether the antibodies we have ajor hindrance to detailed study of anti-islet anti-detected in the serum of patients with insulin-deies in patients with insulin-dependent diabetes pendent diabetes mellitus are pathogenic. The existlitus has been the difficulty in obtaining adequate ence of these antibodies, and of anti-islet antibodies ntities of islet cells. Several recent studies, par-detected by other methods, may be a reflection larly studies employing monoclonal antibody rather than a cause of beta cell damage. Nevertheless, rents, have revealed that continuous cell lines the cytotoxic nature of these antibodies certainly n express cell-surface differentiation antigens raises the possibility that they contribute to beta cell ch are present on the normal cells from which damage. In addition to direct complement-mediated cell line or tumor originated (10, 11) . Our own cytotoxicity, such antibodies may be important for lies of monoclonal antibodies to RINm cells indi-antibody-dependent cell-mediated cytotoxicity. The that these cells express many antigens present on ready availability of these islet cell lines coupled with nal islet cells (7) . The purpose of the present study the speed and quantitative nature of the monolayer to determine whether serum from patients with 5Cr assay should facilitate studies to answer this lin-dependent diabetes mellitus contains anti-question. bodies cytotoxic to these RINm cells. We 
